A Message from the Leaders of NBME and ECFMG|FAIMER

Dear International Medical School Educators, Students, and Graduates:

We recognize that the disruptions to USMLE testing present an extraordinary challenge for all of you. Finding a means to restore USMLE testing is a top organizational priority. Our goal is to collaborate with you as we determine how to assure rapid and safe resumption of testing across a variety of venues. We recognize the impact on both U.S. domestic students as well as those of you in our international community.

Status on Prometric Testing

We are receiving reports that several Prometric test centers are erroneously listed as open, and some examinees with confirmed slots were met with closed centers when Prometric resumed limited testing on May 1st. This has led to a confusing and difficult situation for examinees. We are deeply disturbed by the experience you may be having and are working to immediately find resolution to these issues.

Prometric CEO, Roy Simrell, is aware of our shared dissatisfaction with the current situation and the need for a clear and immediate plan to rectify the problems experienced by examinees. We have been, and continue to be, in daily contact with Prometric to represent the needs of the examinees and faculty to improve the execution of the safe resumption of testing and Prometric’s communication with examinees. We have emphasized the impact their actions have on this critical community and the need to ensure examinees are provided timely and reliable information.

We expect capacity constraints and challenges to continue. For this reason, we are working hard to design and deliver solutions even outside of Prometric test centers.

Alternate Delivery of USMLE Step 1, Step 2 CK, and Step 3

We have several efforts underway to resume testing and to address testing backlog and capacity constraints. We have incorporated the suggestions and ideas we have received from medical students, medical school faculty, state medical boards, and our international partners in this work, and will seek to partner even more closely as we move forward with implementation. We expect to have better insight on feasible alternatives and associated requirements within the next week. We will continue to provide at least weekly updates of our progress at usmle.org and ecfmg.org.

Step 2 CS

We are dedicated to finding a testing solution for Step 2 CS that assures the safety of examinees and standardized patients as our top priority. We have a dedicated team exploring innovative and disruptive solutions to resume Step 2 CS examinations. This includes options that alleviate the need to travel to examination centers. We expect to have more news next week.


Working together, we can respond to the challenges wrought by the COVID pandemic and ensure the continued excellence of America’s future physicians.

Peter J. Katsufrakis, M.D., M.B.A.
President and CEO, National Board of Medical Examiners
William W. Pinsky, M.D., FAAP, FACC
President and CEO, ECFMG|FAIMER
Chair, Board of Trustees, FAIMER
Professor (Hon.), University of Queensland